Jun Abe

611 total citations
31 papers, 475 citations indexed

About

Jun Abe is a scholar working on Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jun Abe has authored 31 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Pharmacology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jun Abe's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Porphyrin Metabolism and Disorders (4 papers). Jun Abe is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Porphyrin Metabolism and Disorders (4 papers). Jun Abe collaborates with scholars based in Japan, United States and Canada. Jun Abe's co-authors include Déborah Braun, Marika Sarfati, Virginie Doyen, Hirohisa Saito, Manuel Rubio, Guy Delespesse, Yoshitaka Tomigahara, Satoshi Kawamura, Hideo Saji and Satoru Takahashi and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Comparative Neurology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Jun Abe

29 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Abe Japan 11 171 94 61 59 55 31 475
Fa‐Li Zhang China 18 316 1.8× 113 1.2× 45 0.7× 85 1.4× 31 0.6× 46 777
Tetsuya Iida Japan 13 313 1.8× 167 1.8× 24 0.4× 51 0.9× 24 0.4× 20 877
M. R. Bleavins United States 14 128 0.7× 57 0.6× 114 1.9× 29 0.5× 24 0.4× 18 463
Anders Peterson Sweden 12 162 0.9× 48 0.5× 43 0.7× 26 0.4× 113 2.1× 24 514
Mika Kawamura Japan 9 312 1.8× 69 0.7× 29 0.5× 70 1.2× 50 0.9× 10 542
Eriko Simamura Japan 15 280 1.6× 68 0.7× 13 0.2× 29 0.5× 27 0.5× 22 532
Sara Sivan Israel 13 553 3.2× 65 0.7× 20 0.3× 82 1.4× 67 1.2× 18 842
Fuko Matsuda Japan 20 595 3.5× 233 2.5× 42 0.7× 23 0.4× 61 1.1× 53 1.4k
Lynn T. Frame United States 14 234 1.4× 38 0.4× 30 0.5× 18 0.3× 86 1.6× 19 545
Heinrich Bürgin Switzerland 13 318 1.9× 33 0.4× 45 0.7× 17 0.3× 34 0.6× 18 510

Countries citing papers authored by Jun Abe

Since Specialization
Citations

This map shows the geographic impact of Jun Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Abe more than expected).

Fields of papers citing papers by Jun Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Abe. The network helps show where Jun Abe may publish in the future.

Co-authorship network of co-authors of Jun Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Abe. A scholar is included among the top collaborators of Jun Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Abe. Jun Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yano, Junji, et al.. (2025). Mode of action analysis for rat thyroid gland follicular cell tumor formation by MGK-264 and human relevance. Regulatory Toxicology and Pharmacology. 160. 105834–105834.
2.
Abe, Jun, et al.. (2023). Novel approach for verification of a human PBPK modeling strategy using chimeric mice in the health risk assessment of epyrifenacil. Toxicology and Applied Pharmacology. 465. 116439–116439. 5 indexed citations
3.
Abe, Jun, et al.. (2022). Evaluation of the mode of action and human relevance of liver tumors in male mice treated with epyrifenacil. Regulatory Toxicology and Pharmacology. 136. 105268–105268. 7 indexed citations
4.
5.
6.
Fujimoto, Keiichi, et al.. (2021). Designing a novel photoinduced electron transfer-based small-molecule fluorescent probe specific for CYP3A isozymes. Bioorganic & Medicinal Chemistry Letters. 47. 128195–128195. 3 indexed citations
7.
Kuroda, Tomohiro, et al.. (2021). Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S‐3100‐CA, in mice. Pharmacology Research & Perspectives. 9(5). e00877–e00877. 9 indexed citations
8.
Kawamura, Satoshi, et al.. (2020). Different effects of an N-phenylimide herbicide on heme biosynthesis between human and rat erythroid cells. Reproductive Toxicology. 99. 27–38. 4 indexed citations
9.
10.
11.
Abe, Jun, Yoshitaka Tomigahara, Hirohisa Nagahori, et al.. (2017). Metabolism of metofluthrin in rats: II. Excretion, distribution and amount of metabolites. Xenobiotica. 48(11). 1113–1127. 1 indexed citations
12.
Abe, Jun, et al.. (2015). Metabolism of (Z)-(1R,3R)-Profluthrin in Rats. Journal of Agricultural and Food Chemistry. 63(39). 8651–8661. 9 indexed citations
13.
Imai, Jin, Katsuto Hozumi, Hideaki Sumiyoshi, et al.. (2015). Anti-fibrotic effects of a novel small compound on the regulation of cytokine production in a mouse model of colorectal fibrosis. Biochemical and Biophysical Research Communications. 468(4). 554–560. 18 indexed citations
14.
Harada, Koichiro, et al.. (2012). Discovery of potent and orally bioavailable 17β-hydroxysteroid dehydrogenase type 3 inhibitors. Bioorganic & Medicinal Chemistry. 20(10). 3242–3254. 16 indexed citations
15.
Kawabe, Mayumi, Satoru Takahashi, Yuko Doi, et al.. (2009). Maternal exposure to anti-androgenic compounds, vinclozolin, flutamide and procymidone, has no effects on spermatogenesis and DNA methylation in male rats of subsequent generations. Toxicology and Applied Pharmacology. 237(2). 178–187. 65 indexed citations
16.
Kitamura, Yoshihisa, Yasuhiko Iida, Jun Abe, et al.. (2006). Release of vesicular Zn2+ in a rat transient middle cerebral artery occlusion model. Brain Research Bulletin. 69(6). 622–625. 27 indexed citations
17.
Kitamura, Yoshihisa, Yasuhiko Iida, Jun Abe, et al.. (2006). Protective Effect of Zinc Against Ischemic Neuronal Injury in a Middle Cerebral Artery Occlusion Model. Journal of Pharmacological Sciences. 100(2). 142–148. 26 indexed citations
18.
Abe, Jun, Hitoshi Okamura, Yasuhiko Ibata, et al.. (1990). Immunocytochemical demonstration of GAP-like immunoreactive neuronal elements in the human hypothalamus and pituitary. Histochemistry and Cell Biology. 94(2). 127–133. 4 indexed citations
19.
Abe, Jun, Hitoshi Okamura, Tadahisa Kitamura, et al.. (1988). Immunocytochemical demonstration of dynorphin(PH‐8P)‐like immunoreactive elements in the human hypothalamus. The Journal of Comparative Neurology. 276(4). 508–513. 16 indexed citations
20.
Abe, Jun, et al.. (1987). Immunocytochemical distribution of [Met]enkephalin-Arg-Gly-Leu immunoreactivity in the rat diencephalon. Brain Research Bulletin. 19(6). 735–741. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fa‐Li Zhang Breakdown of academic impact, for papers by Tetsuya Iida Breakdown of academic impact, for papers by M. R. Bleavins Breakdown of academic impact, for papers by Anders Peterson Breakdown of academic impact, for papers by Mika Kawamura Breakdown of academic impact, for papers by Eriko Simamura Breakdown of academic impact, for papers by Sara Sivan Breakdown of academic impact, for papers by Fuko Matsuda Breakdown of academic impact, for papers by Lynn T. Frame Breakdown of academic impact, for papers by Heinrich Bürgin
Rankless by CCL
2026